|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-6-17
|
|
pubmed:abstractText |
Oxaliplatin is a third-generation platinum compound and a key agent for the management of colorectal cancer. Patients treated with oxaliplatin are at risk for hypersensitivity reactions. We designed a modified premedication regimen to prevent oxaliplatin-related hypersensitivity reactions and assessed if this approach is effective.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1437-7772
|
|
pubmed:author |
pubmed-author:ChibaYasutakaY,
pubmed-author:FujiwaraKimikoK,
pubmed-author:FumitaSoichiS,
pubmed-author:HayashiHidetoshiH,
pubmed-author:KideraYasuhiroY,
pubmed-author:KiyotaHidemiH,
pubmed-author:MakimuraChihiroC,
pubmed-author:MiyazakiMasakiM,
pubmed-author:MoriyamaKenzoK,
pubmed-author:NakagawaKazuhikoK,
pubmed-author:NishidaShozoS,
pubmed-author:OkamotoIsamuI,
pubmed-author:OkamotoKunioK,
pubmed-author:OkamotoWataruW,
pubmed-author:SatohTarohT,
pubmed-author:TsubakiMasanobuM,
pubmed-author:TsurutaniJunjiJ,
pubmed-author:UedaShinyaS,
pubmed-author:YamazoeYuzuruY,
pubmed-author:YonesakaKimioK,
pubmed-author:YoshinagaMasahiroM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
244-9
|
|
pubmed:meshHeading |
pubmed-meshheading:21243395-Adenocarcinoma,
pubmed-meshheading:21243395-Anti-Allergic Agents,
pubmed-meshheading:21243395-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21243395-Cohort Studies,
pubmed-meshheading:21243395-Colorectal Neoplasms,
pubmed-meshheading:21243395-Desensitization, Immunologic,
pubmed-meshheading:21243395-Dexamethasone,
pubmed-meshheading:21243395-Drug Hypersensitivity,
pubmed-meshheading:21243395-Fluorouracil,
pubmed-meshheading:21243395-Histamine Antagonists,
pubmed-meshheading:21243395-Humans,
pubmed-meshheading:21243395-Leucovorin,
pubmed-meshheading:21243395-Organoplatinum Compounds,
pubmed-meshheading:21243395-Premedication,
pubmed-meshheading:21243395-Retrospective Studies
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin.
|
|
pubmed:affiliation |
Division of Pharmacotherapy, Kinki University School of Pharmacy, 3-4-1 Kowakae, Higashi-Osaka, Osaka 577-8502, Japan.
|
|
pubmed:publicationType |
Journal Article
|
